Innovex International, Inc.
NYSE:INVXOil & Gas Equipment & Services
-$0.92 today
- Market cap
- $1.67B
- Beta
- 0.82
- P/E (TTM)
- 33.5
- EPS (TTM)
- $0.75
Volume 0.46M
Average 0.43M
INVX Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Innovex International, Inc.NYSE: INVX
Research & Development · Q3 FY2026 · quarter ended Sep 2026
Research & development remains negative
Q3 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How INVX compares with its peers on the latest reported figures
- INVX's LTM Sep 2026 research & development of $0 is the highest of the 11 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for INVX, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding INVX) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for INVX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 294.84M | 467.19M | 555.54M | 660.8M | 978.25M |
| Cost of Revenue | 207.45M | 309.07M | 360.1M | 428.17M | 735.71M |
| Gross Profit | 87.4M | 158.12M | 195.44M | 232.63M | 242.54M |
| Gross Margin | 29.6% | 33.8% | 35.2% | 35.2% | 24.8% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 55.58M | 59.19M | 72.8M | 116.18M | 128.79M |
| Operating Expenses | 73.32M | 82.27M | 98.16M | 183.56M | 128.79M |
| Depreciation & Amortization | 17.74M | 24.96M | 30.06M | 39.52M | 73.24M |
| EBITDA | 33.59M | 101.92M | 129.93M | 184.77M | 204.35M |
| EBITDA Margin | 11.4% | 21.8% | 23.4% | 28.0% | 20.9% |
| Operating Income | 14.08M | 75.84M | 97.28M | 49.08M | 113.75M |
| Operating Margin | 4.8% | 16.2% | 17.5% | 7.4% | 11.6% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 2.16M | 4.03M | 5.51M | 2.43M | 2.58M |
| Other Income / Expenses | (382K) | (2.91M) | (2.92M) | 93.74M | 14.78M |
| Income Before Tax | 13.7M | 72.93M | 94.37M | 142.81M | 128.53M |
| Pre-Tax Margin | 4.6% | 15.6% | 17.0% | 21.6% | 13.1% |
| Income Tax Expense | 3.84M | 9.65M | 20.44M | 2.49M | 45.23M |
| Net Income | 9.85M | 63.28M | 73.93M | 140.33M | 83.3M |
| Net Margin | 3.3% | 13.5% | 13.3% | 21.2% | 8.5% |
| EPS (Basic) | 0.28 | 4.17 | 2.07 | 2.82 | 1.21 |
| EPS (Diluted) | 0.28 | 4.05 | 1.46 | 2.77 | 1.20 |
| Weighted Avg Shares | 35.28M | 15.18M | 35.78M | 49.73M | 69.01M |
| Weighted Avg Shares (Diluted) | 35.28M | 15.62M | 50.56M | 50.63M | 69.38M |
Innovex International, Inc.
NYSE:INVX
Intrinsic Alpha fair value
Locked
Current Price
$23.79
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.